Analyst firms · BofA Securities · IONS

BofA Securities IONS price target and rating history

Ionis Pharmaceuticals Inc. (IONS) · Health Care

BofA Securities rates Ionis Pharmaceuticals Inc. (IONS) Buy with a $62 price target, as of its latest action on Jan 2, 2024. It has published 3 rating actions on IONS since February 2022, including 2 upgrades and 1 downgrade. Across 6 firms with a IONS price target in the last 12 months, the median target is $99.50.

Current rating
Buy
Price target
$62
Median target, all firms
$99.50
Actions on IONS
3

BofA Securities price target on IONS

$62$46$302023202420252026
BofA Securities price target on IONS, each point a stated target, February 2022 to January 2024.

Every BofA Securities rating on IONS

How other firms rate IONS

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
BMO Capital MarketsOutperform$66Oct 22, 2026
UBSBuy$88Oct 15, 2026
Wolfe ResearchPeer PerformJul 16, 2026
CitigroupBuy$115May 19, 2026
Canaccord GenuityBuy$110Apr 21, 2026
Raymond JamesOutperform$104Apr 10, 2026
BarclaysOverweight$95Jan 28, 2026

Questions about BofA Securities and IONS

What is BofA Securities's price target for IONS?
BofA Securities's latest stated price target for Ionis Pharmaceuticals Inc. (IONS) is $62, from its action on Jan 2, 2024.
What is BofA Securities's rating on IONS?
BofA Securities rates IONS Buy, a bullish rating, as of Jan 2, 2024.
When did BofA Securities last change its view on IONS?
On Jan 2, 2024, BofA Securities upgrades to Buy from Neutral, price target $52 to $62.
How does BofA Securities's IONS target compare with other analysts?
Across 6 firms with a IONS price target in the last 12 months, the median target is $99.50.

More IONS rating histories

All BofA Securities ratingsIONS news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.